Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Onychomycosis in Diabetics: A Common Infection with Potentially Serious Complications.

Life (Basel, Switzerland)·2025
Same author

Artificial Intelligence and Large Language Models in the Fight Against Superficial Fungal Infections: Friend or Foe?

Clinical, cosmetic and investigational dermatology·2025
Same author

Understanding the evolving treatment landscape of hidradenitis suppurativa: An analysis of All of Us.

PloS one·2025
Same author

Onychomycosis in special populations.

Future microbiology·2025
Same author

Management and Genetics of Alopecia Areata within the USA: A Cross-Sectional Study of All of Us.

Skin appendage disorders·2025
Same author

A Canadian Algorithm on the Management of Telogen Effluvium.

Journal of cutaneous medicine and surgery·2025
Same journal

Limitations in the Evidence Base for Bruton Tyrosine Kinase Inhibitors in Chronic Spontaneous Urticaria.

Journal of cutaneous medicine and surgery·2026
Same journal

Adult Cutaneous Chronic Graft-Versus-Host Disease: An In-Depth Review.

Journal of cutaneous medicine and surgery·2026
Same journal

'Cockade' or 'Targetoid' Variant of Syphilis.

Journal of cutaneous medicine and surgery·2026
Same journal

Tinea Imbricata.

Journal of cutaneous medicine and surgery·2026
Same journal

Intergenerational Clouston Syndrome.

Journal of cutaneous medicine and surgery·2026
Same journal

Herpes Zoster Ophthalmicus-Associated Trigeminal Trophic Syndrome.

Journal of cutaneous medicine and surgery·2026
See all related articles

Related Experiment Video

Updated: May 7, 2026

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation
04:43

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation

Published on: May 23, 2025

Laser therapy for onychomycosis.

Aditya K Gupta, Fiona C Simpson

    Journal of Cutaneous Medicine and Surgery
    |September 27, 2013
    PubMed
    Summary
    This summary is machine-generated.

    Laser therapy is approved only for cosmetic onychomycosis (nail fungus) treatment. Current evidence is insufficient to recommend it for eradicating fungal infections, requiring more rigorous trials.

    Related Experiment Videos

    Last Updated: May 7, 2026

    Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation
    04:43

    Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation

    Published on: May 23, 2025

    Area of Science:

    • Dermatology
    • Medical Technology

    Background:

    • Laser therapy is an emerging treatment for onychomycosis (nail fungus).
    • Its application and efficacy require thorough investigation.

    Purpose of the Study:

    • To review current and prospective laser systems for onychomycosis treatment.
    • To assess the available evidence on laser therapy for nail fungus.

    Main Methods:

    • Searched multiple databases (PubMed, FDA 510(k), ClinicalTrials.gov, Google Scholar).
    • Included in vitro studies, clinical trials, and manufacturer white papers.
    • Assessed clinical trials using a 20-point methodological quality scale.

    Main Results:

    • Identified limited basic science and peer-reviewed articles, plus white papers and pending trials.
    • Commercial laser device systems for onychomycosis are available globally.
    • Clinical trials showed moderate methodological quality (average 9.1/20), with peer-reviewed studies scoring higher.

    Conclusions:

    • Laser therapy is currently approved solely for cosmetic onychomycosis treatment.
    • It is not recommended as a therapeutic intervention for fungal infection eradication.
    • More high-quality randomized controlled trials are needed to establish efficacy compared to existing treatments.